Oncologists sometimes check a mesothelioma patient‘s biomarkers, or genetic makeup, to determine which treatment will work best for the patient. However, the aggressive cancer can harbor multiple actionable biomarkers, still leaving the oncologist unsure as to which treatment to use. ...
Enter email for updates from this topic
Want Specific topic updates?